Featured Research

from universities, journals, and other organizations

Medication For ADHD May Help Students Succeed At School

Date:
September 24, 2007
Source:
Mayo Clinic
Summary:
In an 18-year-study on attention-deficit/hyperactivity disorder, Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with ADHD. The Mayo Clinic results are the first population-based data to show stimulant drug therapy helps improve long-term school outcomes.

In an 18-year-study on attention-deficit hyperactivity disorder (ADHD), Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with ADHD.

Related Articles


The Mayo Clinic results are the first population-based data to show stimulant drug therapy helps improve long-term school outcomes.

A related Mayo Clinic study reveals that compared to children without AD/HD, children with ADHD are at risk for poor long-term school outcomes such as low achievement in reading, absenteeism, repeating a grade, and dropping out of school. Both studies appear in the current edition of the Journal of Development & Behavioral Pediatrics.

Nearly 2 million children, or approximately 3 percent to 5 percent of young children in the United States, have ADHD. This disorder affects a child's ability to focus, concentrate and control impulsive behavior. This disorder is so common that most school classrooms have at least one child with clinically-diagnosed ADHD.

"In this study, treatment with stimulant medication during childhood was associated with more favorable long-term school outcomes," explains William Barbaresi, M.D., Mayo Clinic pediatrician and lead author of the reports.

Significance of the Mayo Clinic studies

The two Mayo Clinic studies are the first population-based, long-term studies to investigate links between ADHD, school performance and factors that modify long-term school performance of children with ADHD. Researchers followed the children from the time they were born for, on average, 18 years.

Of the more than 5,000 children evaluated, 370 (277 boys and 93 girls) were identified as having ADHD. Researchers matched them by age and gender to 740 children who did not meet the research criteria for having AD/HD. In addition to medical stimulants such as methylphenidate, also called Ritalin, the study examined the effects on school outcomes of maternal age, socioeconomic background, and special education services the students received.

School outcome results at a glance

The children treated with stimulants typically began taking medication in elementary school and received it for nearly three years -- on average, for 30.4 months.

Results indicate:

Gender: Girls and boys with untreated ADHD were equally vulnerable to poor school outcomes -- and girls may be at risk for being under-identified as having ADHD, and therefore undertreated.

Reading: By age 13, on average, stimulant dose was modestly correlated with improved reading achievement scores.

Absenteeism: Both treatment with stimulants and longer duration of medication were associated with decreased absenteeism.

Grade Retention: Children with A/HD who were treated with stimulants were 1.8 times less likely to be retained a grade than children with ADHD who were not treated.

Implications for parents and caregivers

Dr. Barbaresi believes that both studies provide the first solid evidence of the long-term negative academic performance associated with untreated ADHD -- as well as evidence for the best way to manage this problem.

Dr. Barbaresi says, "The finding that treatment with stimulant medications is associated with long-term improvement in school outcomes is significant. Previously, there was evidence that treatment with stimulant medications improved short-term academic performance, but there was no good evidence that long-term outcomes are better with stimulant treatment. Our data can guide clinicians in their efforts to help children with ADHD succeed in school."

About the studies

The Mayo Clinic team had a unique ability to identify groups of children with and without ADHD. Mayo Clinic has maintained a comprehensive communitywide medical records database since 1935, and researchers had access to all conditions, diagnoses and treatments the children received.

In addition, Mayo obtained a research agreement with Independent School District #535, Rochester, Minn., including public and private schools, to access non-identifiable school records of all children born in Rochester between Jan. 1, 1976 and Dec. 31, 1982. This enabled researchers to correlate school performance of both children with and without ADHD in terms of medical conditions, maternal age, socioeconomic status and special education efforts.

In addition to Dr. Barbaresi, the Mayo Clinic research team also included Slavica Katusic, M.D.; Robert Colligan, Ph.D.; Amy Weaver, M.S.; and Steven Jacobsen, M.D., Ph.D. Their work was supported by grants from the U.S. Public Health Service; National Institutes of Health; McNeil Consumer and Specialty Pharmaceuticals; and Mayo Clinic Foundation for Biomedical Research.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Medication For ADHD May Help Students Succeed At School." ScienceDaily. ScienceDaily, 24 September 2007. <www.sciencedaily.com/releases/2007/09/070918144259.htm>.
Mayo Clinic. (2007, September 24). Medication For ADHD May Help Students Succeed At School. ScienceDaily. Retrieved December 20, 2014 from www.sciencedaily.com/releases/2007/09/070918144259.htm
Mayo Clinic. "Medication For ADHD May Help Students Succeed At School." ScienceDaily. www.sciencedaily.com/releases/2007/09/070918144259.htm (accessed December 20, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, December 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Buzz60 (Dec. 19, 2014) A double-amputee makes history by becoming the first person to wear and operate two prosthetic arms using only his mind. Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins